Mild Traumatic Brain Injury Treatment Market: to witness market growth at a rate of 4.4%, Future Growth, Revenue, Business Opportunities, Key Highlights

Published April 21, 2023

The most recent study released by Reports & Insights highlighted the development and evolution of the global Mild Traumatic Brain Injury Treatment market and also included specific information about the market’s potential and an in-depth understanding of the current trends. According to forecasts in the report, the worldwide Mild Traumatic Brain Injury Treatment market is expected to grow gradually in the foreseeable future. The goal of the research study, “Mild Traumatic Brain Injury Treatment Market: Opportunity Analysis and Future Assessment 2023-2031,” is to present a quantitative and qualitative description of the conceptual structure and analytical approach of the market created using tried-and-true research methodologies and competent skills.

Global Mild Traumatic Brain Injury Treatment Market, by Treatment Type (Pain relievers, Diuretics, Anti-seizure drugs, Coma-inducing drugs), By End Users (Hospitals, Clinics, ASCs), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a healthy CAGR for the period between 2020 and 2028.

The global mild traumatic brain injury treatment market in 2020 is estimated for more than US$ 65.8 Mn and expected to reach a value of US$ 93.0 Mn by 2028 with a significant CAGR of 4.4%.

As per the report, the increasing incidence of brain injuries due to accidents and the prevalence of neurodegenerative diseases is attributed to growth in the mild traumatic brain injury treatment market. As per the Department of Neurology, University of California San Francisco, each year 42 million people across the globe suffer from mild traumatic brain injury (MTBI). As per the CDC, the incidence of post-traumatic brain injury exceeds 600 per 100,000 people across the globe.

Download Free Sample Report

This Mild Traumatic Brain Injury Treatment Market Research/Analysis Report Contains Answers to your following Questions

  • Which Manufacturing Technology is used for Mild Traumatic Brain Injury Treatment? What Developments Are Going On in That Technology? Which Trends Are Causing These Developments?
  • Who Are the Global Key Players in This Mild Traumatic Brain Injury Treatment Market? What are Their Company Profile, Their Product Information, and Contact Information?
  • What Was Global Market Status of Mild Traumatic Brain Injury Treatment Market? What Was Capacity, Production Value, Cost and PROFIT of Mild Traumatic Brain Injury Treatment Market?
  • What Is Current Market Status of Mild Traumatic Brain Injury Treatment Industry? What’s Market Competition in This Industry, Both Company, and Country Wise? What’s Market Analysis of Mild Traumatic Brain Injury Treatment Market by Taking Applications and Types in Consideration?
  • What Are Projections of Global Mild Traumatic Brain Injury Treatment Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?
  • What Is Mild Traumatic Brain Injury Treatment Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
  • What Is Economic Impact On Mild Traumatic Brain Injury Treatment Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
  • What Are Market Dynamics of Mild Traumatic Brain Injury Treatment Market? What Are Challenges and Opportunities?
  • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Mild Traumatic Brain Injury Treatment Industry?

Some of the established risk factors for mild traumatic brain injury are Alzheimer’s disease, Parkinson’s disease, chronic traumatic encephalopathy, and amyotrophic lateral sclerosis (ALS). According to the Alzheimer’s Association, Alzheimer’s disease is the 6th leading cause of death in the U.S> and approximately 5.8 million Americans are suffering from Alzheimer’s disease. In 2019, Alzheimer’s and other dementia are estimated to cost the Nation around US$ 290 billion. Mild traumatic brain injury is an acute brain injury resulting from mechanical energy to the head from external physical forces. MTBI is extremely common. It is estimated that 100 to 300 per 100,000 people seek medical attention for MTBI annually worldwide. Improving the treatment-seeking rate would thus push the market growth for mild traumatic brain injury treatment.

Furthermore, Reports and Insights (R&I) Study identifies that specific populations such as contact sport athletes, victims of domestic violence, military personnel, etc. are at high risk for suffering mild traumatic brain injuries. Treatment for mild traumatic brain injury generally includes symptomatic treatment such as for headaches. Pain relievers such as NSAIDs are prescribed to alleviate pain. Diuretics such as hydrochlorothiazide, torsemide, etc. are given to mild traumatic brain injury patients to reduce the number of body fluids which reduces pressure inside the brain.

People with moderate to severe traumatic brain injury are at the risk of seizures. An anti-seizure drug may be given during the first week to avoid any additional brain damage that might be caused by a seizure. Sometimes coma-inducing drugs such as benzodiazepines are given to the patients of mild traumatic brain injury to relieve pressure on the brain. A comatose brain needs less oxygen to function and this is helpful blood vessels are unable to supply brain cells with nutrients and oxygen.

R&I Study identifies some of the key participating players in the mild traumatic brain injury treatment market globally are Sanis Health Inc., Zydus Pharmaceuticals Usa, Inc., Aurobindo Pharma, Cardinal Health, Pfizer Inc., Apotex Corporation, Mylan Institutional Inc., Hoffman La Roche, Valeant Pharmaceuticals, Sandoz (Novartis), etc, among others.

To Understand How Covid-19 Impact Is Covered in This Report, Ask for Customization:

About Reports and Insights (R&I):

Reports and Insights (R&I) is committed to provide deep insights that serve as creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Reports and Insights (R&I)

Tel: +1-(281)-619-8646

For Sales Queries:

For New Topics and Other Info:

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on


Xherald is passionate about offering extensive coverage of global business news. Dedicated to creating every participant's notification, it reaches its own reader. Daily our experts offer fresh relevant information regarding what is actually occurring in Markets as well as Business. Our headlines are actually swiftly paced and extensive. Our distributor directory connects you with brand new products or services and its market situation from the most effective companies around the planet. Xherald is driven by its 500+ contributors coming from around the world. Xherald provides local as well as global market intelligence information coverage in sectors ranging from healthcare, IOT, chemicals and 17 more sectors. Our updates are quickly paced and detailed. The news we present is actually a mix of authentic content, community contributions and curated headlines announcements. All of the updates our company supplies must pass a strict criterion of genuineness, relevance and significance to our readers.